Last 45 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -2.54 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.75 | 1.38 | 0.95 | 0.71 | 0.84 | 0.93 | 2.33 | 5.07 | 5.19 | 4.13 | 3.99 | 8.00 | 9.26 | 1.93 | 0.61 | 1.32 | 0.23 | 0.72 | 0.79 | 1.70 | 2.78 |
| — | +47.9% | -59.2% | -86.1% | -83.8% | -77.4% | -41.7% | -36.6% | -44.0% | +114.5% | +554.9% | +508.0% | +3885.0% | +167.2% | -23.0% | -22.4% | -91.6% | -81.3% | -83.9% | -76.2% | +35.0% | |
| P/B Ratio | 3.23 | 24.71 | 7.62 | 3.17 | 3.34 | 2.57 | 5.10 | 9.19 | 10.14 | 16.38 | 12.39 | 11.03 | 19.61 | 3.55 | 1.65 | 1.88 | 0.59 | 1.46 | 1.12 | 2.04 | 2.91 |
| — | +860.8% | +49.4% | -65.5% | -67.1% | -84.3% | -58.9% | -16.6% | -48.3% | +361.2% | +653.3% | +485.2% | +3217.8% | +142.7% | +46.4% | -7.6% | -79.7% | -71.5% | -74.5% | -50.7% | +7.8% | |
| P/FCF | — | — | — | — | — | — | — | — | 25.00 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | 265.37 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.7% | 71.3% | 72.1% | 68.2% | 68.6% | 63.8% | 62.7% | 67.2% | 71.4% | 75.4% | 70.8% | 61.2% | 65.3% | 68.7% | 71.8% | 67.0% | 65.0% | 66.5% | 65.5% | 66.7% | 77.4% |
| — | +11.7% | +15.0% | +1.5% | -4.0% | -15.4% | -11.5% | +9.8% | +9.4% | +9.8% | -1.4% | -8.5% | +0.4% | +3.4% | +9.6% | +0.4% | -16.1% | -11.0% | -7.6% | -9.1% | +5.5% | |
| Operating Margin | -35.2% | -14.0% | -19.3% | -31.2% | -24.4% | -34.9% | -47.6% | -35.8% | -2.0% | -10.4% | -14.8% | -103.6% | -51.2% | -39.9% | -18.5% | -77.5% | -55.2% | -71.0% | -78.5% | -70.8% | -67.1% |
| — | +59.9% | +59.5% | +12.8% | -1101.9% | -235.2% | -220.8% | +65.4% | +96.0% | +73.9% | +19.9% | -33.7% | +7.3% | +43.9% | +76.4% | -9.5% | +17.8% | -53.4% | +6.3% | +43.6% | -50.8% | |
| Net Margin | -38.1% | -34.3% | -34.4% | -29.8% | -33.6% | -36.3% | -48.0% | -35.2% | -2.2% | -10.5% | -14.9% | -102.2% | -51.7% | -39.9% | -17.0% | -76.7% | -53.6% | -71.3% | -79.1% | -72.8% | -67.8% |
| — | +5.4% | +28.4% | +15.6% | -1458.8% | -245.9% | -221.8% | +65.5% | +95.8% | +73.7% | +12.4% | -33.2% | +3.6% | +44.0% | +78.5% | -5.4% | +20.9% | -52.0% | +6.3% | +42.6% | -51.3% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -86.2% | -98.7% | -54.2% | -29.5% | -29.3% | -22.7% | -23.6% | -14.9% | -1.5% | -10.2% | -10.9% | -38.6% | -24.6% | -20.5% | -11.0% | -33.1% | -30.6% | -31.1% | -25.1% | -19.9% | -19.1% |
| — | -334.2% | -130.1% | -97.5% | -1815.9% | -123.0% | -116.2% | +61.3% | +93.8% | +50.2% | +0.8% | -16.6% | +19.6% | +34.3% | +56.1% | -66.1% | -59.7% | -104.1% | -42.8% | +7.1% | -38.3% | |
| ROA | -38.5% | -12.2% | -11.2% | -8.0% | -10.5% | -10.1% | -11.6% | -8.3% | -0.9% | -5.9% | -6.9% | -24.7% | -15.6% | -13.4% | -7.5% | -22.1% | -19.4% | -21.2% | -17.9% | -14.8% | -14.6% |
| — | -21.6% | +4.2% | +4.3% | -1080.9% | -69.3% | -69.8% | +66.2% | +94.3% | +55.5% | +8.6% | -11.5% | +19.9% | +36.9% | +58.0% | -49.7% | -33.4% | -81.1% | -31.8% | +11.0% | -28.8% | |
| ROIC | -86.1% | -9.3% | -10.8% | -14.3% | -13.4% | -17.5% | -26.5% | -28.4% | -3.2% | -20.2% | -16.5% | -67.3% | -48.4% | -38.2% | -41.9% | -168.3% | -127.1% | -217.8% | -259.6% | -291.2% | -209.6% |
| — | +46.7% | +59.2% | +49.8% | -313.8% | +13.6% | -60.8% | +57.8% | +93.3% | +47.0% | +60.7% | +60.0% | +61.9% | +82.5% | +83.9% | +42.2% | +39.4% | -60.1% | +69.0% | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.70 | 7.78 | 3.44 | 2.11 | 1.70 | 0.84 | 0.71 | 0.38 | 0.33 | 0.03 | 0.04 | 0.04 | 0.07 | 0.06 | 0.04 | 0.05 | 0.09 | 0.08 | 0.07 | 0.07 | 0.05 |
| — | +825.6% | +388.1% | +452.4% | +418.2% | +3229.8% | +1776.5% | +755.1% | +390.3% | -60.8% | +3.2% | -3.4% | -23.2% | -24.0% | -50.7% | -31.2% | +82.6% | +43.4% | +15.8% | +27.1% | +218.1% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | 36.73 | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 3.30 | 1.92 | 2.31 | 2.73 | 3.30 | 2.49 | 2.39 | 2.66 | 3.22 | 2.10 | 2.34 | 2.83 | 2.49 | 2.78 | 2.91 | 3.28 | 2.56 | 2.69 | 3.43 | 3.57 | 4.46 |
| — | -23.2% | -3.1% | +2.6% | +2.4% | +18.6% | +1.9% | -5.8% | +29.3% | -24.3% | -19.6% | -13.9% | -2.6% | +3.3% | -15.0% | -8.0% | -42.6% | -39.2% | -33.7% | -26.6% | -11.5% | |
| Quick Ratio | 2.93 | 1.66 | 2.01 | 2.36 | 2.93 | 2.10 | 2.03 | 2.38 | 2.91 | 1.62 | 1.94 | 2.40 | 2.16 | 2.52 | 2.60 | 2.88 | 2.17 | 2.33 | 3.10 | 3.35 | 4.27 |
| — | -20.7% | -1.1% | -0.8% | +0.5% | +29.5% | +4.9% | -0.9% | +34.6% | -35.7% | -25.5% | -16.9% | -0.3% | +8.3% | -16.0% | -13.8% | -49.2% | -45.3% | -37.2% | -28.3% | -10.8% | |
| Interest Coverage | -15.24 | -6.38 | -6.45 | -4.59 | -4.04 | -361.03 | — | — | — | — | — | — | — | — | — | — | -54.71 | — | — | — | -526.10 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 45 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MYO stock.
Myomo, Inc.'s current P/E is -2.5x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Myomo, Inc.'s current operating margin is -35.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Myomo, Inc.'s business trajectory between earnings reports.